Target intelligence / Profile preview

Transmembrane 4 L6 family member 5 (TM4SF5)

Target
TM4SF5
Molecular classification
Tetraspanin, Transmembrane protein, Lysosomal membrane protein, Arginine sensor
01

Overview

Transmembrane 4 L6 family member 5 (TM4SF5) is a cell-surface glycoprotein belonging to the transmembrane 4 L6 family, which is closely related to the tetraspanin family. It features four transmembrane domains and two extracellular loops, forming tetraspanin-enriched microdomains (TERMs) that act as signaling hubs on the cell membrane. TM4SF5 plays a critical role in regulating cell proliferation, migration, invasion, and epithelial-mesenchymal transition (EMT) by interacting with integrins, growth factor receptors (such as EGFR), and cytosolic signaling molecules like focal adhesion kinase (FAK) and c-Src. Additionally, TM4SF5 acts as a lysosomal membrane arginine sensor, regulating mTORC1 signaling and hepatocyte nutrient metabolism. TM4SF5 is aberrantly overexpressed in various malignancies, including hepatocellular carcinoma, colorectal cancer, pancreatic cancer, and esophageal cancer, where it promotes tumor progression, metastasis, and drug resistance. It is also implicated in chronic liver diseases such as nonalcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), and liver fibrosis. Consequently, TM4SF5 is a promising therapeutic target, with several monoclonal antibodies, antibody-drug conjugates (such as BCG015), and small-molecule inhibitors (such as TSAHC and RCT-1213) under preclinical development to neutralize its activity and suppress tumor growth.

Other names
Transmembrane 4 superfamily member 5Tetraspan transmembrane protein L6HIL-TMPL6H
02

Mechanism of action

Inhibition of TM4SF5-mediated signaling, neutralization of TM4SF5, antibody-dependent cellular cytotoxicity (ADCC), or antibody-drug conjugate (ADC) mediated cytotoxicity.

03

Biological functions

Cell proliferationCell migrationCell invasionEpithelial-mesenchymal transitionSignal transductionArginine sensingAngiogenesisMetabolism regulation
04

Disease associations

CancerHepatocellular carcinomaColorectal cancerPancreatic cancerEsophageal cancerLiver fibrosisNonalcoholic fatty liver diseaseNonalcoholic steatohepatitis
05

Safety considerations

Potential on-target off-tumor toxicity in normal tissues expressing TM4SF5 (e.g., normal intestinal tissue)Immunogenicity of monoclonal antibodiesSystemic toxicity of antibody-drug conjugates (ADCs)
06

Interacting drugs

5 more in the full profile.

07

Biomarkers

TM4SF5 expressionE-cadherin expressionVimentin expressionFAK phosphorylationc-Src phosphorylationSTAT3 phosphorylation

Beyond the preview

Go deeper on Transmembrane 4 L6 family member 5 (TM4SF5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transmembrane 4 L6 family member 5 (TM4SF5).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call